Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials

Cells(2022)10.3390/cells11040687Source: DataRank Database

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.96)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Charles P. Emerson ORCID,Lawrence J. Hayward ORCID,Mehdi Ghasemi ORCID

Live enrichment

PubMed:35203336 PMC:PMC8870318 OpenAlex:https://openalex.org/W4212973946

NICHD NIH HHS

Grant: P50 HD060848

National Institutes of Health

Grant: 5P50HD060848-15

Novel Therapeutics for FSHD

FWCI

1.96

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/11/4/687/pdf?version=1645089904

publisherhttps://www.mdpi.com/2073-4409/11/4/687/pdf?version=1645089904

publisherhttps://www.mdpi.com/2073-4409/11/4/687/pdf

journalhttps://doi.org/10.3390/cells11040687

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35203336

Fields of Study

Muscle Physiology and DisordersProsthetics and Rehabilitation RoboticsMuscle activation and electromyography studies0301 basic medicine03 medical and health sciences0302 clinical medicineHomeodomain ProteinsHumansMuscle, SkeletalMuscular Dystrophy, FacioscapulohumeralOutcome Assessment, Health Care

MeSH Terms

HumansOutcome Assessment, Health CareHomeodomain ProteinsMuscle, SkeletalMuscular Dystrophy, Facioscapulohumeral

Keywords

Facioscapulohumeral muscular dystrophyMuscular dystrophyPhysical medicine and rehabilitationMedicineClinical trialPhysical therapyInternal medicineMagnetic resonance imaging (MRI)Outcome MeasuresFacioscapulohumeral Muscular Dystrophy (Fshd)Double Homeobox 4 (Dux4)double homeobox 4 (<i>DUX4</i>)ReviewCongenitalOutcome Assessment, Health CareHumansMusculoskeletal DiseasesMuscle, SkeletalNeuralHomeodomain ProteinsQH573-671Muscular Dystrophy, FacioscapulohumeralCellular and Molecular PhysiologyHereditaryMusculoskeletaland Ocular PhysiologyNervous System DiseasesCytologyand Neonatal Diseases and Abnormalities

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials

FAIR Checklist

Authors (3)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)